Novoron Bioscience

About Novoron Bioscience

Novoron Bioscience is dedicated to pioneering lipoprotein-receptor drug development to repair damage and degeneration in the brain, spinal cord, and beyond. Their mission is to develop innovative therapies to restore independence and improve patients' lives through multi-modality discovery and optimized drug delivery.

Products & Services

Proteinopathies:Developing small molecule therapies to block the spread of prion-like proteins, aiming to prevent neurodegeneration and cognitive decline.

Neuroregeneration:Enhancing the regenerative capacity of the spinal cord following traumatic injury.

Specialties

Lipoprotein-receptor drug development Neurological health and repair Small molecule therapies for proteinopathies Neuroregeneration for spinal cord injuries

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBIR Grant T: - FT: SBIR Grant	A: 2500000 MR: - FA: 2.5 million FAN: 2500000	D: 2026-01-06 FD: 2026-01-06	1 investors

SBIR Grant Latest

2026-01-06

$2.5M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Travis Stiles

CEO, Co-founder, Chairman of the Board

D

David Weiner, MD

Executive Chairman

W

William Hoekstra

Drug Discovery & Development

L

Lynne Mayman

Pre-Clinical Development & Project Management

S

Sarah Busch

Non-Clinical Translation & Business Development

R

Ryan McMillian

CFO

View 16 more team members with Pro

Unlock Full Team Directory

Recent News